Press Release: Research Into Medicinal Cannabis Treatment of Coronavirus

Press Release: Research Into Medicinal Cannabis Treatment of Coronavirushttps://www.pharmiweb.com/press-release/2020-04-27/research-into-medicinal-cannabis-for-treatment-of-coronavirus

The Company’s collaboration partner for the detailed analysis of the molecular makeup of the strains which Ananda proposes to grow and stabilise is Dr Dedi Meiri, based at The Technion in Israel, and widely regarded as one of the world’s foremost cannabis scientists. Dr Meiri has now commenced a new project to assess whether the anti-inflammatory and anti-viral properties of medicinal cannabis have benefits as a preventative measure and treatment for Covid-19 (and similar diseases).

His lab’s research will be focused on four aspects of the potential of cannabis to dampen the hyperinflammatory response, involving the ‘cytokine storm’ (proteins released by cells to coordinate the body’s immune response against infection), to the Covid-19 virus which is believed to cause much of the tissue damage as well as pulmonary edema, fever, and in severe cases ARDS (Acute Respiratory Distress Syndrome), septic shock and eventually multiple organ dysfunction.